ACA

Avoro Capital Advisors Portfolio holdings

AUM $5.71B
1-Year Return 11.37%
This Quarter Return
+0.51%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$6.74B
AUM Growth
+$48M
Cap. Flow
+$283M
Cap. Flow %
4.2%
Top 10 Hldgs %
73.21%
Holding
39
New
2
Increased
16
Reduced
2
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GLUE icon
26
Monte Rosa Therapeutics
GLUE
$305M
$33.7M 0.5%
4,325,000
MRSN icon
27
Mersana Therapeutics
MRSN
$34M
$31M 0.46%
302,000
RARE icon
28
Ultragenyx Pharmaceutical
RARE
$3.07B
$30.1M 0.45%
750,000
MRNS
29
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$21.7M 0.32%
3,150,000
WHWK
30
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
$20.6M 0.31%
2,849,402
DSGN icon
31
Design Therapeutics
DSGN
$367M
$20.2M 0.3%
3,500,000
+1,227,778
+54% +$7.08M
VRCA icon
32
Verrica Pharmaceuticals
VRCA
$48.2M
$17.2M 0.26%
+265,000
New +$17.2M
PMVP icon
33
PMV Pharmaceuticals
PMVP
$77.4M
$14.6M 0.22%
3,060,000
AMLX icon
34
Amylyx Pharmaceuticals
AMLX
$910M
$13.9M 0.21%
473,100
-156,900
-25% -$4.6M
FENC icon
35
Fennec Pharmaceuticals
FENC
$250M
$9.98M 0.15%
1,200,000
MCRB icon
36
Seres Therapeutics
MCRB
$169M
$7.34M 0.11%
+64,750
New +$7.34M
TNGX icon
37
Tango Therapeutics
TNGX
$772M
$6.48M 0.1%
1,640,000
IOBT icon
38
IO Biotech
IOBT
$128M
$3.84M 0.06%
2,055,883
XBI icon
39
SPDR S&P Biotech ETF
XBI
$5.39B
0